Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9373146 | 0.85 | CYP2C9 (0.46) | ALDH1A1TP53KMT2ACYP2C19CYP2C9 | |
| SCHEMBL4296465 | 0.72 | HPGD (0.57) | ALDH1A1SMN1; SMN2GAA | |
| SCHEMBL13865073 | 0.72 | TSHR (0.71) | ALDH1A1TSHRL3MBTL1TP53KMT2A | |
| SCHEMBL3504947 | 0.71 | HPGD (0.58) | ALDH1A1L3MBTL1KMT2ACYP2C19CYP2C9 | |
| SCHEMBL9372814 | 0.71 | HPGD (0.58) | ALDH1A1L3MBTL1KMT2ACYP2C19CYP2C9 | |
| SCHEMBL7475648 | 0.71 | HPGD (0.58) | ALDH1A1L3MBTL1KMT2ACYP2C19CYP2C9 | |
| SCHEMBL7476802 | 0.70 | TRPV6 (0.46) | SMN1; SMN2 | |
| SCHEMBL845279 | 0.69 | ALDH1A1 (0.53) | ALDH1A1TP53KMT2ACYP2C19CYP2C9 | |
| SCHEMBL21874295 | 0.68 | EP300 (0.75) | L3MBTL1KMT2AMAPK1 | |
| SCHEMBL29510867 | 0.68 | EP300 (0.75) | L3MBTL1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020133004-A1 | Process for producing new oxazepine derivatives | AJINOMOTO CO. INC (JP) | 2002-09-19 | — | — | US | claimed |
| EP-1219611-A4 | NOVEL PROCESSES FOR PREPARING OXAZEPINE DERIVATIVES | AJINOMOTO KK (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-20020133004-A1 | Process for producing new oxazepine derivatives | AJINOMOTO CO. INC (JP) | 2002-09-19 | — | — | US | disclosed |
| WO-2001017980-A1 | NOVEL PROCESSES FOR PREPARING OXAZEPINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2001-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133004-A1 | Process for producing new oxazepine derivatives | KMO, CYP4B1, GRIN2B | ALDH1A1 391/4885TSHR 3628/4885L3MBTL1 3497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.